Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials

Reactogenicity and Immunogenicity of Vaginal CNgp140 (SG06RS02)

This study has been terminated.
(IMP expired prior to completion of recruitment)
Sponsor:
Collaborators:
Bill and Melinda Gates Foundation
York Hospitals
Information provided by:
St George's, University of London
ClinicalTrials.gov Identifier:
NCT00637962
First received: March 11, 2008
Last updated: February 10, 2011
Last verified: February 2011
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has been terminated.
  Study Completion Date: January 2009
  Primary Completion Date: October 2008 (Final data collection date for primary outcome measure)
No publications provided by St George's, University of London

Publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):